ImmunoCellular Therapeutics, Ltd.
Clinical-stage cell immunotherapy platform for cancer treatment
- Sector
- Biotech
- Headquarters
- MONTVALE, NJ
- Latest Form D
- $750K, Sep 2022
- Total capital
- $13.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $13.3M
- 4 Form D · last Sep 2022
- 49 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 4 pending · first 2013
- Rank in peer group#397 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$750K
- Private capital raisedForm D · SEC · 3rd filing$8.1M
- Private capital raisedForm D · SEC · 2nd filing$2.7M
- Private capital raisedForm D · SEC · 1st filing$1.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#397 · top 27%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- James Kirk BenderResearcherExecutive OfficerLinked by 1 patent
- Manish SinghResearcherExecutive Officer, DirectorLinked by 1 patent
- C. Kirk PeacockExecutive OfficerNamed in SEC Form D filings
- Eli GoldbergerExecutive Officer, DirectorNamed in SEC Form D filings
- Frank DouglasDirectorNamed in SEC Form D filings
- Irach TaraporewalaExecutive Officer, DirectorNamed in SEC Form D filings
Show all 15 people
- Jacqueline Kirk BrandwynneDirectorNamed in SEC Form D filings
- John S. YuDirectorNamed in SEC Form D filings
- Julie KampfDirectorNamed in SEC Form D filings
- Navdeep A. JaikariaDirectorNamed in SEC Form D filings
- Rahul A. SinghviDirectorNamed in SEC Form D filings
- Richard A. CowellDirectorNamed in SEC Form D filings
- Robert LehmanDirectorNamed in SEC Form D filings
- Robert L. MartuzaDirectorNamed in SEC Form D filings
- Wayne DansonExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 6- GrantedCancer Vaccines And Vaccination MethodsUSPTOUS 10,137,182
- PendingCancer Vaccines And Vaccination MethodsUSPTOApplication 14181417
- GrantedCD133 EpitopesUSPTOUS 8,604,167
Show all 6 patent records
- Cancer Vaccines And Vaccination MethodsNov 27, 2018 · US 10,137,182Granted
- Cancer Vaccines And Vaccination MethodsAug 21, 2014 · Application 14181417Pending
- CD133 EpitopesDec 10, 2013 · US 8,604,167Granted
- Cancer Vaccines And Vaccination MethodsApplication PCTUS2014016610Pending
- Cancer Vaccines And Vaccination MethodsApplication 61764789Pending
- CD133 EpitopesApplication PCTUS2010034082Pending
Related companies, and why
- NANOVIRICIDES, INC.Similar federal contract value in Biotech · null in contracts
- Causeway Therapeutics LtdSimilar federal contract value in Biotech · null in contracts
- Carmine Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Morphoceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Genprex, Inc.Similar federal contract value in Biotech · null in contracts
- Convelo Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .